Brian Schwartz
Directeur Technique/Scientifique/R&D chez INTENSITY THERAPEUTICS, INC.
Fortune : 46 596 $ au 31/05/2024
Postes actifs de Brian Schwartz
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ENLIVEX THERAPEUTICS LTD. | Directeur/Membre du Conseil | 01/12/2020 | - |
| CYCLACEL PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 17/12/2020 | - |
| Directeur Technique/Scientifique/R&D | 25/01/2024 | - | |
| Independent Dir/Board Member | 17/12/2020 | 25/01/2024 | |
| INTENSITY THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | - | - |
Historique de carrière de Brian Schwartz
Anciens postes connus de Brian Schwartz
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| INFINITY PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 07/09/2021 | 24/07/2023 |
| MEREO BIOPHARMA GROUP PLC | Directeur/Membre du Conseil | 01/10/2020 | 10/11/2022 |
| VINCERX PHARMA, INC. | Directeur/Membre du Conseil | 05/03/2020 | 23/12/2020 |
| Independent Dir/Board Member | 05/03/2020 | 23/12/2020 | |
| ARQULE, INC. | Directeur Technique/Scientifique/R&D | 01/06/2008 | 01/03/2020 |
| ALAUNOS THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 01/01/2008 | - |
| Conseiller Juridique Général | 01/01/2008 | - |
Formation de Brian Schwartz
| University of Pretoria | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 7 |
| Afrique du Sud | 2 |
| Royaume-Uni | 2 |
Opérationnelle
| Director/Board Member | 5 |
| Chief Tech/Sci/R&D Officer | 4 |
| Independent Dir/Board Member | 2 |
Sectorielle
| Health Technology | 8 |
| Consumer Services | 2 |
| Finance | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 6 |
|---|---|
| MEREO BIOPHARMA GROUP PLC | Health Technology |
| ENLIVEX THERAPEUTICS LTD. | Health Technology |
| CYCLACEL PHARMACEUTICALS, INC. | Health Technology |
| INFINITY PHARMACEUTICALS, INC. | Health Technology |
| ALAUNOS THERAPEUTICS, INC. | Health Technology |
| INTENSITY THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
ArQule, Inc.
 ArQule, Inc. Pharmaceuticals: MajorHealth Technology ArQule, Inc. is a biopharmaceutical company, which engages in the research and development of therapeutics to treat cancers and rare diseases. The company was founded in 1993 and is headquartered in Burlington, MA. | Health Technology |
LifeSci Acquisition Corp.
 LifeSci Acquisition Corp. Financial ConglomeratesFinance LifeSci Acquisition Corp. operates as a blank check company. It was formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more businesses or entities. The company was founded on December 19, 2018 and is headquartered in New York, NY. | Finance |
- Bourse
- Insiders
- Brian Schwartz
- Expérience
